Form 4: Cytokinetics Director Sells Shares in Recent Transaction
SEC Form 4 Filing
Robert Arthur Harrington, a director at Cytokinetics Inc, sold 1,580 shares of common stock at a price of $48.64 per share on June 3, 2024.
Summary
- On June 3, 2024, Robert Arthur Harrington, a director of Cytokinetics Inc, sold 1,580 shares of the company's common stock.
- The sale price was $48.64 per share.
- Following the transaction, Harrington directly owns 15,541 shares of Cytokinetics Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to a stock transaction by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.
Industry Context
This transaction is a routine disclosure of insider trading activity. It's common for directors and officers of publicly traded companies to buy and sell shares of their company's stock. These transactions are closely monitored by regulators and investors to ensure compliance with insider trading laws.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, but it is a relatively small transaction and may not have a significant impact.
Key Dates
| Date | Description |
|---|---|
| 06/03/2024 | Date of the stock sale transaction |
| 06/05/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.